Literature DB >> 10650321

Design and implementation of the North American Pediatric Cardiomyopathy Registry.

M A Grenier1, S K Osganian, G F Cox, J A Towbin, S D Colan, P R Lurie, L A Sleeper, E J Orav, S E Lipshultz.   

Abstract

The Pediatric Cardiomyopathy Registry (PCMR) was established to describe the epidemiologic features and clinical course of selected cardiomyopathies in patients aged 18 years or younger and to promote the development of etiology-specific treatments. Sixty-one private and institutional pediatric cardiomyopathy practices in the United States and Canada were recruited to participate in the PCMR. The registry consists of a prospective, population-based cohort of patients in 2 regions (New England and the Central Southwestern United States) and a retrospective cohort of patients diagnosed between 1991 and 1996. Annual follow-up data are collected on all patients. As of June 1999, the PCMR consisted of 337 prospectively identified and 990 retrospectively identified patients. The PCMR has demonstrated the feasibility of establishing a large database of sociodemographic and clinical information on children with pediatric cardiomyopathy. Through this cooperative effort, the PCMR will obtain precise estimates of the incidence of pediatric cardiomyopathy and a better understanding of the natural history of this disease.

Entities:  

Mesh:

Year:  2000        PMID: 10650321     DOI: 10.1067/mhj.2000.103933

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  38 in total

Review 1.  The pediatric cardiomyopathy registry and heart failure: key results from the first 15 years.

Authors:  James D Wilkinson; David C Landy; Steven D Colan; Jeffrey A Towbin; Lynn A Sleeper; E John Orav; Gerald F Cox; Charles E Canter; Daphne T Hsu; Steven A Webber; Steven E Lipshultz
Journal:  Heart Fail Clin       Date:  2010-10       Impact factor: 3.179

2.  Incidence of and risk factors for sudden cardiac death in children with dilated cardiomyopathy: a report from the Pediatric Cardiomyopathy Registry.

Authors:  Elfriede Pahl; Lynn A Sleeper; Charles E Canter; Daphne T Hsu; Minmin Lu; Steven A Webber; Steven D Colan; Paul F Kantor; Melanie D Everitt; Jeffrey A Towbin; John L Jefferies; Beth D Kaufman; James D Wilkinson; Steven E Lipshultz
Journal:  J Am Coll Cardiol       Date:  2012-02-07       Impact factor: 24.094

3.  Genetic Testing in Pediatric Cardiomyopathy.

Authors:  Chalani D Ellepola; Linda M Knight; Peter Fischbach; Shriprasad R Deshpande
Journal:  Pediatr Cardiol       Date:  2017-11-29       Impact factor: 1.655

4.  Recovery of echocardiographic function in children with idiopathic dilated cardiomyopathy: results from the pediatric cardiomyopathy registry.

Authors:  Melanie D Everitt; Lynn A Sleeper; Minmin Lu; Charles E Canter; Elfriede Pahl; James D Wilkinson; Linda J Addonizio; Jeffrey A Towbin; Joseph Rossano; Rakesh K Singh; Jacqueline Lamour; Steven A Webber; Steven D Colan; Renee Margossian; Paul F Kantor; John L Jefferies; Steven E Lipshultz
Journal:  J Am Coll Cardiol       Date:  2014-02-19       Impact factor: 24.094

5.  Early predictors of survival to and after heart transplantation in children with dilated cardiomyopathy.

Authors:  Biagio A Pietra; Paul F Kantor; Heather L Bartlett; Clifford Chin; Charles E Canter; Ranae L Larsen; R Erik Edens; Steven D Colan; Jeffrey A Towbin; Steven E Lipshultz; James K Kirklin; David C Naftel; Daphne T Hsu
Journal:  Circulation       Date:  2012-07-16       Impact factor: 29.690

6.  Risk stratification at diagnosis for children with hypertrophic cardiomyopathy: an analysis of data from the Pediatric Cardiomyopathy Registry.

Authors:  Steven E Lipshultz; E John Orav; James D Wilkinson; Jeffrey A Towbin; Jane E Messere; April M Lowe; Lynn A Sleeper; Gerald F Cox; Daphne T Hsu; Charles E Canter; Juanita A Hunter; Steven D Colan
Journal:  Lancet       Date:  2013-09-03       Impact factor: 79.321

7.  Thrombotic events in critically ill children with myocarditis.

Authors:  Kimberly Y Lin; Basavaraj Kerur; Char M Witmer; Lauren A Beslow; Daniel J Licht; Rebecca N Ichord; Beth D Kaufman
Journal:  Cardiol Young       Date:  2013-09-09       Impact factor: 1.093

8.  No Obesity Paradox in Pediatric Patients With Dilated Cardiomyopathy.

Authors:  Chesney D Castleberry; John L Jefferies; Ling Shi; James D Wilkinson; Jeffrey A Towbin; Ryan W Harrison; Joseph W Rossano; Elfriede Pahl; Teresa M Lee; Linda J Addonizio; Melanie D Everitt; Justin Godown; Joseph Mahgerefteh; Paolo Rusconi; Charles E Canter; Steven D Colan; Paul F Kantor; Hiedy Razoky; Steven E Lipshultz; Tracie L Miller
Journal:  JACC Heart Fail       Date:  2018-02-07       Impact factor: 12.035

9.  Toward Personalized Medicine: Does Genetic Diagnosis of Pediatric Cardiomyopathy Influence Patient Management?

Authors:  Teresa M Lee; Stephanie M Ware
Journal:  Prog Pediatr Cardiol       Date:  2015-07-01

10.  Nutrition in Pediatric Cardiomyopathy.

Authors:  Tracie L Miller; Daniela Neri; Jason Extein; Gabriel Somarriba; Nancy Strickman-Stein
Journal:  Prog Pediatr Cardiol       Date:  2007-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.